Remedies in antitrust enforcement serve as essential instruments to stop ongoing anticompetitive conduct, prevent its recurrence, and address its effects by restoring competitive conditions in the market. Remedies are a core component of the enforcement toolkit, enabling authorities to ensure that their interventions are effective.
Two guiding principles consistently underpin remedy design: effectiveness and proportionality. These, in turn, involve considerations on causality between the harm and the remedy, and enforceability of the measures. Achieving remedies that are both effective and proportionate is a complex task, requiring not only knowledge of the market dynamics but also a careful judgment and an in-depth case-by-case analysis. In this regard, competition authorities can enhance the effectiveness of the process by using a co-operative approach to design their remedies. Engaging parties, market participants, sector regulators and other relevant actors can enhance the quality, feasibility and legitimacy of remedies. Such inclusive design processes contribute to more robust outcomes, reinforcing the overall effectiveness of antitrust enforcement.
Competition authorities may initiate a dialogue with different actors early in the process. As with co-operation in other stages of an investigation or a merger review, early contact is desirable. Co-operation may also be key in identifying the competition concerns that require the imposition of a remedy, the alternatives of remedies that can address the issues, and the aspects of efficiency and proportionality of those alternatives. It can also be useful in assessing practicability, implementability and enforceability and, in later stages, in monitoring compliance.
While co-operating with stakeholders will always bring challenges related to issues like resources, timing, procedures, legal limitations and even trust and reciprocity, there are strategies that can be followed to achieve effective levels of co-operation. Ultimately, the way authorities deal with these challenges will shape how co-operation in remedy design looks like.
There are several strategies that competition authorities already employ to facilitate collaboration in remedy design, as identified in the paper and that could be considered, when possible and suitable. They can be considered around early engagements with stakeholders, the need for transparent communication of objectives and possible outcomes, the use of different tools to leveraging the different stakeholders’ expertise and adjusting mechanisms that give flexibility to remedy design.